Trial Profile
Study of Tau Imaging with [F-18]MK6240 across the AD Spectrum
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2018
Price :
$35
*
At a glance
- Drugs Florquinitau F18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 05 Oct 2018 New trial record